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Previous studies conducted in our laboratory have demonstrated that intestinal barrier 
function can be adversely affected by diet ingredients or feed restriction, resulting in 
increased intestinal inflammation-associated permeability. Two experiments were con-
ducted in broilers to evaluate the effect of three concentrations of Aflatoxin B1 (AFB1; 
2, 1.5, or 1 ppm) on gastrointestinal leakage and liver bacterial translocation (BT). In 
experiment 1, 240 day-of-hatch male broilers were allocated in two groups, each group 
had six replicates of 20 chickens (n = 120/group): Control feed or feed + 2 ppm AFB1. In 
experiment 2, 240 day-of-hatch male broilers were allocated in three groups, each group 
had five replicates of 16 chickens (n = 80/group): Control feed; feed + 1 ppm AFB1; or 
feed + 1.5 ppm AFB1. In both experiments, chickens were fed starter (days 1–7) and 
grower diets (days 8–21) ad libitum and performance parameters were evaluated every 
week. At day 21, all chicks received an oral gavage dose of FITC-d (4.16 mg/kg) 2.5 h 
before collecting blood samples to evaluate gastrointestinal leakage of FITC-d. In exper-
iment 2, a hematologic analysis was also performed. Liver sections were aseptically 
collected and cultured using TSA plates to determine BT. Cecal contents were collected 
to determine total colony-forming units per gram of Gram-negative bacteria, lactic acid 
bacteria (LAB), or anaerobes by plating on selective media. In experiment 2, liver, spleen, 
and bursa of Fabricius were removed to determine organ weight ratio, and also intestinal 
samples were obtained for morphometric analysis. Performance parameters, organ 
weight ratio, and morphometric measurements were significantly different between 
Control and AFB1 groups in both experiments. Gut leakage of FITC-d was not affected 
by the three concentrations of AFB1 evaluated (P >  0.05). Interestingly, a significant 
reduction in BT was observed in chickens that received 2 and 1 ppm AFB1. An increase 
(P < 0.05) in total aerobic bacteria, total Gram negatives, and total LAB were observed 
in chickens fed with 2 and 1.5 ppm of AFB1 when compared with Control and 1 ppm 
chickens. The integrity of gut epithelial barrier was not compromised after exposure to 
the mycotoxin.
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inTrODUcTiOn
In the winter of 1959, the British cargo ship Rosetti, unloaded 
a shipment of peanut meal from Brazil to England, which was 
utilized as a protein supplement in the diets of poultry and 
other domestic animals. By summer of 1960, an outbreak of 
an unknown disease killed several species of poultry including 
turkeys, ducklings, and pheasants. In all, 500 cases were reported 
involving the deaths of more than 100,000 turkeys. This was the 
first report of Turkey “X” Disease (1, 2). Exhaustive research led to 
the discovery of aflatoxins, secondary metabolites of Aspergillus 
flavus and Aspergillus parasiticus, as the etiological agents and 
the development of mycotoxicology (3–5). More recent studies 
demonstrated that aflatoxins are potent carcinogenic compounds 
(6–11). About 14 different types of aflatoxins are produced in 
nature (10, 12), but aflatoxin B1 (AFB1) produced by A. flavus 
and A. parasiticus is considered the most toxic (13, 14). In spite 
of 55  years of continuous research on aflatoxins, several areas 
of aflatoxicosis remain yet to be investigated. It is particularly 
interesting that studies on poultry aflatoxicosis have not kept 
pace with the research in mammals, and there still exists an 
incomplete description of aflatoxicosis in avian species, especially 
when searching for scientific publications related to the effect(s) 
of aflatoxins on the gastrointestinal tract (GIT).
The GIT is the first organ coming into contact with mycotox-
ins from the diet and should be expected to be affected by AFB1 
with greater potency as compared to other organs. Nevertheless, 
literature regarding the effects of AFB1 on the GIT is particularly 
confusing. Few researchers have look at morphometric changes 
following dietary administration of aflatoxins in chickens, tur-
keys, and ducks, but results from those studies contradict each 
other, particularly when looking at villi high and villi to crypt 
ratio (10, 11, 15–20). Similarly, contradictive results arise from 
the effects of AFB1 on digestibility of amino acids, energy utiliza-
tion, and absorption of macronutrients (18, 20–27).
Aflatoxins are absorbed very quickly into the blood from the 
GIT, followed by an extensive transformation into metabolites 
primarily in the liver (9, 28, 29). Contrary to the studies on 
mucosal damage and nutrient absorption caused by AFB1, there 
is an universal agreement that beside the carcinogenic and hepa-
totoxic effects on the liver, dietary aflatoxins reduce weight gain, 
feed intake (FI), increase feed conversion ratio (FCR), and are 
immunosuppressive (12, 30, 31).
Today, only a few reports could be found in databanks, in 
which the issue of barrier function and intestinal permeability 
has been reported. From recent studies by Yunus et  al. (19) in 
broilers, it has been suggested that the absorptive surface of 
small intestine declines during a chronic exposure to low levels 
of AFB1. However, in that study, broilers compensated for the 
reduced absorptive surface by increasing the length of the small 
intestine (19). In the second study, transepithelial electrical resist-
ance (TEER), used as an important indicator of barrier function 
of intestinal epithelial cells (IEC), showed that AFB1 was only 
moderately affect during acute exposure to the toxin (10). As far 
as we can tell, the only study of the effect of AFB1 on possible 
damage to tight junctions (TJs) was performed by Caloni et al. 
(32) who demonstrated that AFB1 does not affect the integrity of 
TJ proteins or barrier damage in vitro.
We have previously shown that intestinal barrier function can 
be adversely affected by poorly digested diets, feed restriction, or 
dexamethasone resulting in increased intestinal inflammation-
associated permeability in poultry (33–36). The purpose of the 
present investigation was to evaluate the effect of three doses of 
aflatoxin B1 on growth, physiological parameters, and gut perme-
ability in broiler chickens.
MaTerials anD MeThODs
animal source, Diets, and experimental 
Design
Two experiments were conducted several weeks apart using two 
hundred and forty 1-day-old male broiler chicks (Cobb-Vantress, 
Silom Springs, AR, USA) raised in floor pens. Unmedicated 
corn-soybean-based broiler starter and medicated (with coc-
cidiostat) corn-soybean-based broiler grower diets were prepared 
according to the broiler’s recommendations (37). Experiments 
were conducted to evaluate the effect of three concentrations of 
AFB1 (2 ppm in experiment 1 and 1.5 or 1 ppm in experiment 
2) on systemic fluorescein isothiocyanate-dextran (FITC-d; 
3–5 kDa) levels and liver bacterial translocation (BT) as indica-
tors of increased gut epithelial leakage. AFB1 was provided by 
Dr. George E. Rottinghaus, Veterinary Medical Diagnostic 
Laboratory, University of Missouri, Columbia, MO, USA. AFB1 
was produced through the fermentation of rice and the aflatoxin 
content was measured by spectrophotometric analysis. The afla-
toxin within the rice powder consisted of 74.62% AFB1, 22.38% 
AFG1, 2.48% AFB2, and 0.49% AFG2, based on total aflatoxin 
in the rice powder. Diets containing AFB1 were analyzed, and 
the presence of parent AF was confirmed by high-performance 
liquid chromatography with fluorescence detection (HPLC-FLD) 
method by using a Romer Derivatization Unit (Romer Labs, Inc., 
MO, USA). AFB1 was added to the diets and mixed thoroughly 
in a graded sequence to specified concentrations. The birds were 
given diets with or without supplemental AFB1 and water ad libi-
tum. All animal handling procedures were in compliance with the 
Institutional Animal Care and Use Committee at the University 
of Arkansas. In experiment 1, broilers were allocated randomly to 
two groups, each group had six replicates of 20 chickens (n = 120/
group): Control feed or feed +  2 ppm AFB1. In experiment 2, 
broilers were allocated randomly to three groups, each group 
had five replicates of 16 chickens (n = 80/group): Control feed; 
feed + 1 ppm AFB1; or feed + 1.5 ppm AFB1. In both experi-
ments, chickens were fed starter (days 1–7) and grower diet (days 
8–21) ad  libitum until the end of the experiment at day 21. In 
each experiment, each pen was used as a replicate and also as an 
experimental unit per treatment to evaluate body weight (BW), 
body weight gain (BWG), FI, and FCR. These growth performance 
parameters were obtained every week. At the end of experiment 
2, blood samples were collected from the wing vein into tubes 
with heparin as anticoagulant for differential cell counts. In both 
experiments, 21-day-old chickens received an oral gavage dose 
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of FITC-d (4.16 mg/kg) 2.5 h before collecting blood samples to 
evaluate passage of FITC-d. Chickens were humanely killed by 
CO2 asphyxiation. Blood was collected from the femoral vein to 
obtain serum for FITC-d determination (as described below) and 
serum clinical chemistry (in experiment 2 only) with a Corning 
clinical chemistry analyzer (Chiron Corporation, San Jose, CA, 
USA). Liver sections (n = 12 chickens/treatment) were aseptically 
collected to determine BT, and cecal contents were collected to 
determine total colony-forming units per gram of Gram-negative 
bacteria, lactic acid bacteria (LAB), or anaerobes by plating on a 
selective media as described below.
Determination of hematological 
Parameters
Differential counts of blood samples collected from experiment 
2 were determined using a Cell-Dyne 3500 System (Abbott 
Laboratories, Chicago, IL, USA) that had been standardized for 
differential counts of poultry blood cells. Hematologic measure-
ments of heparin anticoagulated blood included total numbers of 
white blood cells (WBC), heterophils, lymphocytes, monocytes, 
eosinophils, and basophils. Heterophil/lymphocyte ratios (H/L), 
an indicator of stress in birds (38), were calculated by dividing the 
number of heterophils in 1 mL of peripheral blood by the number 
of lymphocytes. Total counts of red blood cells, hemoglobin 
(HGB), hematocrit (HCT)%, mean corpuscular volume (MVC), 
and mean corpuscular hemoglobin (MCH) were also determined. 
Additionally, in experiment 2, liver, spleen, and bursa of Fabricius 
were removed and cleaned of adherent tissues. The weight of 
these organs was measured and expressed as percentage of BW 
(organs weight/final BW) × 100.
serum Determination of FiTc-d
Blood samples were kept at room temperature for 3 h and cen-
trifuged (1,000 × g for 15 min) to separate the serum from the 
red blood cells. FITC-d levels of undiluted serum were measured 
at excitation wavelength of 485 nm and emission wavelength of 
528  nm (Synergy HT, Multi-mode microplate reader, BioTek 
Instruments, Inc., VT, USA). Fluorescence measured was then 
compared to a standard curve with known FITC-d concentra-
tions. Gut leakage for each bird was reported as microgram of 
FITC-d/mL of serum (35, 36).
Bacterial Translocation
The number of birds used was based on published studies, in which 
similar variables were measured (34, 39). Briefly, the right half of 
the liver was removed from each chicken, collected in sterile bags, 
homogenized, weighed, and 1:4 wt/vol dilutions were made with 
sterile 0.9% saline. Ten-fold dilutions of each sample from each 
group were made in a sterile 96-well Bacti flat bottom plate, and 
the diluted samples were plated on tryptic soy agar plates (TSA, 
catalog no. 211822, Becton Dickinson, Sparks, MD, USA).
Determination of Microbial level in ceca
Both ceca were aseptically removed, placed into sterile bags, and 
homogenized. Samples were weighed, and 1:4  wt/vol dilutions 
were made with sterile 0.9% saline. Ten fold dilutions of each 
sample from each group were made in a sterile 96-well Bacti flat 
bottom plate, and the diluted samples were plated on four differ-
ent culture media to evaluate the total number of LAB in deMan 
Rogosa Sharpe (Difco™ Lactobacilli MRS Agar VWR Cat. No. 
90004-084 Suwanee, GA, USA); total recovered Gram-negative 
bacteria in MacConkey; total anaerobes in tryptic soy agar with 
sodium thioglycolate plates (TSA, catalog no. 211822, Becton 
Dickinson, Sparks, MD, USA); and total yeast in Sabouraud 
Glucose Agar Base with antibiotics, tetraciclina, and 100-mg 
sodium benzyl penicillin (HiMedia Laboratories Pvt. Ltd., 
Mumbai, India).
histology and Morphometric analysis of 
intestine
Intestinal sections from duodenum (~1-cm section was collected 
from the middle of the descending duodenum), and ileum 
(0.5-cm section was obtained from the mid-ileum at Meckel’s 
diverticulum) were fixed in 10% neutral buffered formalin and 
embedded in paraffin, sectioned (5 μm thick), set on a glass slide, 
and stained with hematoxylin and eosin (H&E), and then exam-
ined by light microscopy. Photomicrographs of randomly selected 
fields of each intestinal sample were acquired using a microscope 
equipped with a Leica DFC450C camera and Leica v.3.8.Software 
(Leica Application Suite) and used for morphometric analysis. 
ImageJ 1.47v software (http://rsb.info.nih.gov/ij/) was used for 
the morphometric measurements of villus length, villus width, 
and crypt depth. Under a magnification of 2×, 10 villi per bird 
per section were measured, with a total of five birds per group. 
Villus length was measured from the top of the villus to the upper 
part of the lamina propria. Crypt depth was measured from the 
base upwards to the region of transition between the crypt and 
villus (40). Villus width was measured at the widest area of each 
villus, whereas villus:crypt ratio was determined dividing villus 
height into crypt depth values. Villus surface area was calculated 
using the formula (2π)(VW/2)(VL), where VW =  villus width 
and VL = villus length (41).
statistical analysis
All data were subjected to analysis of variance as an entirely 
randomized design using the General Linear Models procedure 
of SAS (42). Data were expressed as mean ± SE. Significant dif-
ferences among the means were determined by using Duncan’s 
multiple-range test at P < 0.05.
resUlTs
Performance Parameters
Body weight of chickens fed 2 ppm of AFB1 was not affected in 
the first week; however, BW was significantly (P < 0.05) reduced 
by 18.36 and 34.89% during the second and third weeks of age, 
respectively, when compared with Controls (Table 1). BW gain 
and FI were also affected by AFB1 consumption with a reduction 
of 20% for both variables during the second week and 37 and 49%, 
respectively, in the third week. FCR only showed a significant 
difference in the third week with an improvement in the AFB1 
group when compared with Controls (Table 1). Administration 
TaBle 1 | effect of dietary administration of 2, 1.5, and 1 ppm of aflatoxin B1 on body weight (BW), body weight gain (BWg), feed intake, and feed 
conversion ratio at 7, 14, and 21 days in broiler chickens or experiments 1 and 2.
experiment 1 experiment 2
Parameters control 2 ppm aFB1 control 1 ppm aFB1 1.5 ppm aFB1
BW (g/Broiler)
Day 7 144.79 ± 1.85a 142.05 ± 1.04a 136.82 ± 2.87a 134.92 ± 2.44a 133.34 ± 2.74a
Day 14 385.88 ± 5.02a 315.42 ± 5.40b 337.03 ± 9.38a 309.76 ± 2.21b 298.95 ± 5.03b
Day 21 771.55 ± 8.61a 502.28 ± 7.90b 690.45 ± 19.36a 581.99 ± 8.54b 511.03 ± 11.47c
BWg (g/Broiler)
Days 0–7 97.83 ± 1.71a 95.07 ± 1.03a 93.24 ± 2.71a 90.40 ± 2.9a 88.62 ± 2.89a
Days 7–14 338.88 ± 4.85a 268.45 ± 5.07b 293.48 ± 9.20a 265.22 ± 2.11b 254.13 ± 4.74b
Days 14–21 724.60 ± 8.46a 455.30 ± 7.92b 646.65 ± 18.94a 537.47 ± 8.37b 466.22 ± 11.19c
Feed intake (g/Broiler)
Days 0–7 132.1 ± 1.92a 127.44 ± 1.62a 131.35 ± 3.17a 128.34 ± 2.94a 126.42 ± 3.44a
Days 7–14 505.65 ± 5.86a 405.94 ± 6.12b 405.49 ± 13.15a 406.08 ± 6.40a 399.36 ± 14.80a
Days 14–21 966.15 ± 17.74a 489.09 ± 16.53b 790.56 ± 40.09a 670.32 ± 17.08b 570.14 ± 53.87c
Feed conversion ratio
Days 0–7 1.35 ± 0.01a 1.34 ± 0.01a 1.41 ± 0.02a 1.42 ± 0.01a 1.43 ± 0.02a
Days 7–14 1.49 ± 0.02a 1.51 ± 0.01a 1.39 ± 0.06b 1.53 ± 0.01a 1.57 ± 0.03a
Days 14–21 1.33 ± 0.02a 1.08 ± 0.04b 1.23 ± 0.09a 1.25 ± 0.02a 1.22 ± 0.09a
a–cSuperscripts within rows indicate significant (P < 0.05) difference within each experiment.
TaBle 2 | effect of 1 and 1.5 ppm of aflatoxin B1 on body weight ratios 
for liver, spleen, and bursa of Fabricius in 21-day-old broiler chickens.
Treatment liver ratio (%) spleen ratio 
(%)
Bursa of Fabricius 
ratio (%)
Control 3.24 ± 0.09b 0.11 ± 0.01b 0.15 ± 0.01b
1 ppm AFB1 3.60 ± 0.19a,b 0.16 ± 0.02a 0.20 ± 0.02a
1.5 ppm AFB1 4.23 ± 0.34a 0.15 ± 0.01a 0.18 ± 0.02a,b
Experiment 2.
Mean ± SE from 10 chickens.
a,bSuperscripts within columns indicate significant difference at P < 0.05.
TaBle 3 | effect of 2 ppm of aflatoxin B1 (experiment 1) or 1 and 1.5 ppm 
of aflatoxin B1 (experiment 2) on total bacterial and yeast counts from 
cecum samples in broiler chickens at 21 days.
Diet ceca (log10 cfu/g of tissue)
Total aerobic 
bacteria
Total gram-
negative 
bacteria
Total lactic 
acid bacteria
Total yeast
experiment 1
Control 6.41 ± 0.19a 6.08 ± 0.22b 5.75 ± 0.21b 3.13 ± 0.20a
2 ppm 
AFB1
6.83 ± 0.29a 7.00 ± 0.21a 6.56 ± 0.13a 3.33 ± 0.07a
experiment 2
Control 6.98 ± 0.23b 6.51 ± 0.37b 6.91 ± 0.14a 2.74 ± 0.33a
1 ppm 
AFB1
7.25 ± 0.22b 7.04 ± 0.24a,b 6.33 ± 0.15b 3.36 ± 0.18a
1.5 ppm 
AFB1
7.82 ± 0.17a 7.66 ± 0.15a 7.22 ± 0.16a 2.86 ± 0.33a
Data are expressed as mean ± SE from 12 chickens.
a,bSuperscripts within columns indicate significant difference at P < 0.05.
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of 1 and 1.5 ppm of AFB1 also decreased BW by 8 and 11% during 
the second week and 16 and 26% in the third week, respectively, 
compared with Controls. This reduction was proportionally simi-
lar in BWG being 10 and 13% lower for 1 and 1.5 ppm of AFB1 
during the second week, and 17 and 28% for 1 and 1.5 ppm during 
the third week. FI was not affected by AFB1 consumption during 
the first 2 weeks; however, there was a reduction of 15 and 28% 
in fed intake in chickens that consumed 1 and 1.5 ppm of AFB1, 
respectively, during the last week (Table 1). FCR varied accord-
ingly in the three diet groups during the whole experiment except 
the second week where Control group had a more efficient ratio 
compared to the AFB1 groups (Table 1). In experiment 2, the liver 
weight ratio was significantly increased in chickens that received 
1.5 ppm when compared with Control (Table 2). However, spleen 
ratio was increased in both groups of chickens that received 1 or 
1.5 ppm of AFB1 when compared with Controls. Bursa ratio was 
increased only in chickens that received 1 ppm (Table 2).
Total Bacterial counts in cecum
In experiment 1, chicks receiving 2 ppm of AFB1 had an increase 
in the number of total Gram-negative bacteria and total LAB, 
but the total numbers of aerobes were similar between chickens 
that received 2 ppm of AFB1 and Control chickens (Table 3). In 
experiment 2, the total number of aerobic bacteria and total Gram 
negatives were higher in 1.5 ppm AFB1 group. Conversely, the 
number of total LAB was reduced in chickens fed with 1 ppm 
AFB1. No difference was observed in total yeast count between 
groups in neither of both experiments (Table 3).
hematology
In experiment 2, a significant heterophilia with a marked lympho-
penia was observed in both groups that received AFB1 (Table 4). 
Consequently, an increase in the heterophils-to-lymphocyte ratio 
was also observed in those groups when compared with Controls. 
No significant differences were found in the numbers of mono-
cytes, eosinophils, or basophils (data not shown). Hemoglobin, 
MVC, and MCH were significantly decreased in chickens that 
consumed 1.5  ppm of AFB1 when compared with Controls. 
TaBle 4 | effect of 1 and 1.5 ppm of aflatoxin B1 on blood parameters 
and serum chemistry in broiler chickens at 21 days.
hematological 
parameters
Treatments
control 1 ppm aFB1 1.5 ppm aFB1
White blood cells 30.02 ± 4.57a 27.89 ± 2.50a 37.20 ± 4.23a
Heterophils 13.21 ± 1.38b 26.39 ± 2.04a 28.62 ± 2.70a
Lymphocytes 77.15 ± 2.07a 62.58 ± 3.31b 58.08 ± 2.11b
Heterophils lymph. 
ratio (HLR)
0.18 ± 0.02b 0.45 ± 0.05a 0.51 ± 0.06a
Red blood cells 1.81 ± 0.09a 1.70 ± 0.04a 1.68 ± 0.06a
Hemoglobin (HGB) 5.98 ± 0.17a 5.56 ± 0.18a 4.90 ± 0.13b
Hematocrit (HCT)% 44.95 ± 2.41a 42.07 ± 1.33a 39.23 ± 1.29a
Mean corpuscular 
volume (MVC)
248.1 ± 2.83a 247.0 ± 3.23a 234.4 ± 3.19b
Mean corpuscular 
hemoglobin (MCH)
33.58 ± 1.15a 32.63 ± 0.56a,b 29.42 ± 0.81b
Experiment 2.
Mean ± SE from 10 chickens.
a,bSuperscripts within rows indicate significant difference at P < 0.05.
TaBle 5 | effect of 2 ppm of aflatoxin B1 (experiment 1) or 1 and 1.5 ppm 
of aflatoxin B1 (experiment 2) on liver bacterial translocation and serum 
FiTc-d levels in broiler chickens at 21 days.
Diet liver bacterial translocationc  
(log10 cfu/g of tissue)
FiTc-dc (μg/ml 
of serum)
experiment 1
Control 2.77 ± 0.50a 0.34 ± 0.01a
2 ppm AFB1 1.13 ± 0.49b 0.39 ± 0.05a
experiment 2
Control 1.51 ± 0.46a 0.34 ± 0.02a
1 ppm AFB1 0.00 ± 0.00b 0.31 ± 0.02a
1.5 ppm AFB1 1.30 ± 0.47a 0.31 ± 0.01a
a,bSuperscripts within columns indicate significant difference at P < 0.05.
cData are expressed as mean ± SE, n = 12 birds/treatment.
TaBle 6 | Morphometric analysis of duodenum and ileum samples from broiler chickens at 21 days.
Duodenum ileum
Parameters control 1 ppm aFB1 1.5 ppm aFB1 control 1 ppm aFB1 1.5 ppm aFB1
Villus length (μm) 382.41 ± 5.03c 398.40 ± 2.01b 437.00 ± 7.50a 164.32 ± 3.75c 175.42 ± 3.13b 199.78 ± 3.42a
Villus width (μm) 45.22 ± 1.66a 45.83 ± 1.38a 47.74 ± 1.50a 38.93 ± 0.68a 37.69 ± 1.33a 32.57 ± 0.78b
Crypt depth (μm) 31.83 ± 1.03a 26.01 ± 0.79b 24.35 ± 0.15b 23.24 ± 0.49b 21.51 ± 0.69b 26.67 ± 0.67a
Villus height/crypt depth ratio 12.45 ± 0.33c 16.03 ± 0.48b 18.06 ± 0.39a 7.11 ± 0.12c 8.49 ± 0.24a 7.58 ± 0.10b
Villus surface area (mm2)d 0.054 ± 0.019b 0.057 ± 0.001b 0.066 ± 0.002a 0.020 ± 0.005a 0.021 ± 0.009a 0.020 ± 0.007a
Experiment 2.
a–cSuperscripts within rows within intestinal section indicate significant difference at P < 0.05.
dSurface was calculated as [2π × (villus width/2) × (villus height)] (41).
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(Table 5). Interestingly, there were no differences in serum levels 
of FITC-d levels between Control and treated chickens. On the 
other hand, in experiment 2, chicks fed 1.5 ppm AFB1 did not 
show significant differences in BT when compared with Control 
chickens, but no bacteria recovery was observed from livers of 
chickens fed with 1 ppm AFB1. Nevertheless, similar to experi-
ment 1, no significant differences were observed in the levels of 
serum FITC-d between chicks that received 1 or 1.5 ppm of AFB1 
and Control chickens (Table 5).
Morphometric analysis
Villus length in both duodenum and ileum sections was signifi-
cantly increased in a dose-related fashion in chickens that received 
1 and 1.5 ppm of AFB1 when compared with Control chickens 
(Table 6). However, a significant reduction in duodenum crypt 
depth was observed in chickens that received 1 and 1.5 ppm of 
AFB1 when compared with Control chickens. On the other hand, 
similar changes in ileum crypt depth were found in chickens that 
received 1.5 ppm of AFB1 when compared with Control or 1 ppm 
chickens. Changes in duodenum villus height/crypt depth ratio 
were inconsistent between doses of AFB1 in this study.
In the ileum, this relationship was increased in chickens that 
received 1 ppm, followed by chicks that received 1.5 ppm of AFB1 
and Control chickens had the lower villus height/crypt depth 
ratio. The surface area of the duodenum was significantly higher 
in chicks that received 1.5 ppm of AFB1, but no changes in ileum 
surface area were observed between the three groups (Table 6).
DiscUssiOn
Aflatoxins have several effects in poultry, including poor per-
formance, liver pathology, immunosuppression, and changes in 
relative organ weights (30, 31, 43, 44). Our results were consistent 
with these previous studies demonstrating dose-related effects on 
reduction of BW, BWG, FI, and feed conversion as well as increase 
relative weights of liver, spleen, and bursa of Fabricius.
In spite of the indicated antimicrobial potential of AFB1, we 
found few reports regarding the effects of the toxin on gut micro-
bial populations. Kubena et al. (44) reported a significant increase 
in total volatile fatty acids at 5 days of age in chickens that received 
2.5 and 7.5 ppm of AFB1, suggesting changes in LAB populations 
(45, 46). In other studies, Lactobacillus spp. have been noted to 
change under the influence of AFB1; however, these changes did 
These values were not affected in chickens that received 1 ppm 
when compared with Controls (Table 4).
Bacterial Translocation and FiTc-d 
leakage
Chickens receiving a diet with 2 ppm of AFB1 had a significant 
reduction in BT to the liver when compared to Control chickens 
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not warrant any beneficial effects of AFB1 on intestinal microbial 
population (47).
In the present study, AFB1 significantly increased the total 
number of Gram-negative bacteria in chickens fed with 2 and 
1.5 ppm and numerically in chickens fed with 1 ppm, and a simi-
lar trend was observed in the total number of LAB for chickens 
receiving 2 and 1.5 ppm of AFB1. However, chickens that received 
1  ppm showed a significant reduction of total LAB but higher 
total number of aerobic bacteria when compared with Control 
chickens. Interestingly, little information about the outcomes of 
AFB1 on gut microbiome is available. In one study, Kubena et al. 
(44) reported that 2.5 ppm of AFB1 increased the production of 
total volatile fatty acids in broilers, which suggest higher number 
of total LAB populations. In the present study, no differences were 
observed in total yeast counts between groups in neither of both 
experiments; nevertheless, we could not find any other report to 
compare our results. Perhaps, such inconsistent results may be 
a reason of the lack of publications reporting yeast evaluation. 
Interestingly, it has been showed that fermentation patterns of 
Saccharomyces cerevisiae also change under the influence of AFB1 
(48). AFB1 has also been reported to change fermentation pat-
terns with increase gas production, due to fermentation of other 
carbohydrates of LAB, that affects negatively the cheese industry 
(46, 47, 49). Several investigators have reported the effects that 
aflatoxins cause to heterophilia lymphopenia and hemolytic 
anemia in poultry (6, 10, 30, 50, 51). In experiment 2, a dramatic 
increase in the heterophils occurred while the lymphocytes 
were reduced. Consequently, an increase in the heterophils- 
to-lymphocyte ratio was also observed in those groups when 
compared with Control chickens. A similar response of circulating 
leukocytes was also found when a physiological stress was applied 
to chickens (38). In aflatoxicosis, the spleen is enlarged due to the 
hemolytic anemia (52) and some reports indicate that the spleen 
of chickens is almost doubled in size (53). In experiment 2, spleens 
of chickens that received 1 and 1.5 ppm were significantly larger 
when compared with Control. The elevated WBC counts caused 
by both doses of AFB1 also support the clinical presentation of 
hemolytic anemia. Additionally, hemoglobin, MVC, and MCH 
were significantly increased in chickens that consumed 1.5 ppm 
of AFB1 when compared with Control chickens, confirming that 
aflatoxicosis causes a hemolytic anemia in chickens as has been 
previously reported (30, 51, 52, 54, 55).
We have previously shown that intestinal inflammation can 
be induced by diet ingredients or stress, affecting intestinal 
permeability (33–36). As the largest barrier in the body, IEC are 
responsible for absorption of water and nutrients, but they also 
prevent the entry of antigens into the blood (56–58).
Contrary to our initial hypothesis, 2  ppm of AFB1 did 
not increase intestinal permeability, as was evidenced by a 
significant reduction in BT or similar levels of serum FITC-d 
when compared with Control chickens. It is possible that the 
inflammation of the liver that is characterized by infiltration of 
heterophils and other inflammatory cells may handle cleaning 
any bacterial leakage that arrives from the porta system to the 
liver. Those results encouraged us to repeat and extend the 
experiment with lower doses of AFB1 and by comparing the 
morphometric changes between Control and treated groups. Our 
findings from experiment 2 showed that chickens fed 1.5 ppm 
AFB1 showed a numerical reduction in BT when compared with 
Control chickens, but no bacteria were recovered from livers of 
chickens fed with 1 ppm AFB1. Also, similar to experiment 1, 
no significant differences were observed in the levels of serum 
FITC-d between chicks that received 1 or 1.5 ppm of AFB1 and 
Control chickens.
Increased intestinal leakage is also associated with BT in the portal 
circulation (59, 60). Likewise, FITC-d is a bulky molecule (3–5 kDa) 
which is not observed under normal conditions. Nevertheless, if TJs 
between epithelial cells are altered, FITC-d can be detected in serum, 
indicating damage to the TJs following FITC-d gavage administration 
(61). It has been reported that AFB1 does not destroy TJs (32), it has 
only minor effects on the gut-associated lymphoid tissue (GALT) (62), 
confirming that AFB1 does not induce inflammation in the GIT.
Literature reports on the effects of AFB1 on histology of GIT 
are limited and not conclusive (10, 11, 18, 27, 63). However, it is 
important to mention that the few studies that have evaluated 
the effect of AFB1 on intestinal histology are reports using dif-
ferent concentrations of AFB1, different avian species, different 
ages, as well as time of AFB1 administration. Interpretation of 
our morphometric results was also inconclusive. Nevertheless, 
the GIT is highlighted as a dynamic organ that is able to adapt 
to a chronic AFB1 as has been demonstrated by several scientists 
(18, 20–23, 26, 27). In summary, the results of the present study 
suggest that AFB1 does not increase gut leakage as is evidenced 
by the lack of increase permeability of FITC-d in the serum. On 
the other hand, further studies are needed to clarify the BT and 
morphometric results with AFB1.
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